Вы находитесь на странице: 1из 8

2 2013

616.89008.441.1:616.12
.. , .. , .. , ..
. .





, , -
. , -
( , , -
, .), .
,
.

:
.

 (
 (), , , 
. [35, 47, 55]  , ,
 ) [8, 50, 53].
6,417%. 
 
,  . (I II)
[10]. ,  DSM (Diagnostic and Statistical Manual of Mental Disorders)

,  . 
. 100 .
 [18]. : 
 , ,
 . , 
(), () ,
, [1].
[8]. ,  , 
[45]   
( ,  ,
) . 
(),  

(), .  [36, 40]. 
 

  . , 
.
[23, 27].

,  , 
, , ,
,  . , . Bayani et al. [19],

72 .. , .. , .. , .. , 2013

2 2013

28,5%.  , 
. , ,
66% .
() [56] 2431%  
[42], 1145%  
() [59], 3539% . 
[29], 29% , 
[51], , 
5,3% [34]. , ,
[15], 
64 (46 , 18 ) [14].
,  
38 (59,4%). 
,
,
() . [40, 44].
, 

[16]. , , 
.
: 
(33,90,9, 
36,70,8 40,10,6 II, III IV ()
; p<0,01)
(35,20,6, 36,80,5, 39,90,7 II, III IV 
; p<0,01). ,  () [6].
, , , 
. ,
[14].
 , 
1,7 , 5,9 [14]. 
, , 

28%, [37].
  . Kayano et al. [41],
35% [24].
, , ,
[49],
, ,  .
, 3 ,

 . .
 ,
 ,
, , 
[25]. 
,
S.B. Patten et al. [47], 1 , , 
 ,
 , .
, , , M.U. Zafar et al. [61], 
, .
, 
, , , ,
. .
,

 , 

73

2 2013

. [30, , ,
39, 52]  , 
,
 . [9].
, 

[49]. , [21],  , , 
 , , , ,
:  ..,
. , .

,  ,
, , , 
, , , , ,
, , ,
 , , , 
. , , 
.
10  , 
[35]: ,
; [2].
;
;
; [12].
. 
, ,  , 
DSMIV . 
[17]: 
1. /  , ,
; 
2. ( ,
); ..
3.  ; , , 
4. ; ,
5. ; . 
6. ;
7. . ,
 ,
,  , .
.

[3]: ,
; , ..
.

( , , , , 
). [45],
. ,  ,
, ,
.
. ,
,  
. .
 
, , , 
. ,  ,
, , ,
, , , ,  ,

74

2 2013

,
, , ,  2 (2item Generalized Anxiety
, , Disorder scale GAD2). , 
.  
:
. ,
?.
. , 
[5], 85 (52 
33 , 66,48,5 ) : (Hamilton
IIIV , Anxiety Scale), (Beck Anxiety inventory), (Zung
68 SelfRating Depression Scale), 
(1 ). 17 (2 )  (Hospital Anxiety Depression Scale),
. SF36 7 (7item Generalised Anxiety
1 , Disorder Scale) . 

(36,59,8), (34,310,5)  STOPD
(31,912,2). (Screening Tool for Psychological Distress), 5
2
11 (64,7%) [60].
(30,711,3)
(41,615,4).

 . 
.

,  .
, 
,
, . 
.
, , , 
,  .
, . , 
.. ,
,  : , 
[17]. , ,  , , ,
: , ,
1. , .. ,

6 . , , 
2. . . 
3. , , 
(  
6 ): [13, 32].
,
; , 
, ; , [31]:
; (, , ,
; );
; (
. , , );
National Collaborating 
Centre for Mental Health [26], () (, , );
() (
, );

. (, ).

75

2 2013

. , ,
,
, ,  .. [43]. 
,
.  , , [28, 33].

. ,
,  .
 , [4] 47 (31 
,  16 , 65,26,1 )
,  IIIV NYHA.
,  IIIII , 29
(61,7%) .
[11, 12].
(35,90,9 
.  ) (38,10,7 ) .

5 3 
, 2 
. ,  ( 10 3 ). 
 3 . 
. , ,
 (29,60,8 ; p<0,001),
[7, 54, 58]. (32,40,6 ; p<0,01). 
SF36 
, 
,  ( , 
.  15,74,6 
,  19,98,1 ). 
, :
. 3060
( 24 )  ,
( 10 ;
, , . ,
)
[38, 46, 57]. 
 .
, , 
. , , 
[13, 20].
 , 
, [50].
. 
, , 
.  .
,
,  ,
[48]. (5HT)  , ,
1 ,  
, ,  .
, , 
, . ,
, 
[22]. .
,

, , 1. ..
 

76

2 2013

? / .. // 14. .. 
. 2006. 5. . 36.
2. ..  / .. // . 2004. . 12,
/ .. // . 22. . 12771283.
2010. 7. . 5658. 15. . , , 
3. .. :   
, / .. // 
. . . 2006. . 14, 4. . 328336. / . 
4. .. , . // XVII 

(, 2224 2013 .). . 47.
/ .. , .. , ..  16. ..
, .. // , VI 
, 2122 2013, . . / .. , .. 
5. ..  , .. // III 

/ .. , (, 2526 2013 .).
.. , .. , .. : 1 17. American Psychiatric Association. Diagnostic and
 Statistical Manual of Mental Disorders (DSMIVTR) /
, 46 2013 ., . // Washington: American Psychiatric Association. 2000.
. . . 2013. 2 ( 2). 943 p.
. 3637. 18. Barger S.D. Does generalized anxiety disorder predict
6. ..  coronary heart disease risk factors independently of
: major depressive disorder? / S.D. Barger, S.J. Sydeman //
  Journal of Affective Disorders. 2005. Vol. 88.
/ .. // . . . ( P. 8791.
. ). 2008. . 16, 12. . 1712 19. Bayani B. Depression and Anxiety in a Cardiovascular
1719. Outpatient Clinic: A descriptive study / B. Bayani,
7. ..  S. Yousefi, M. Bayani et al. // Iran J. Psychiatry. 2011.
Vol. 6, 3. P. 125127.
/ .. , 20. Bazire S. Psychotropic drug directory / S. Bazire //
.. , .. . // Bath Press, Bath, 2003.
. 2006. 2. 21. Benninghoven D. Influence of anxiety on the course of
. 2327. heart disease after acute myocardial infarctionrisk
8. .. factor or protective function? / D. Benninghoven,
 / C..  A. Kaduk, U. Wiegand et al. // Psychother Psychosom.
// . 2006. 2. . 2024. 2006. Vol. 75. P. 5661.
9. .. :  22. Bohm C. 
/ .. // . . . : 
2005. . 13, 15. . 17.  /
10. .. C. Bohm, D.S. Robinson, R.E. Gammans et al. //
  (
/ .. , ). 2008. 243.
.. , .. // 23. Bunker S.J. Stress and coronary heart disease:
. 2007. psychosocial risk factors / S.J. Bunker, D.M. Colguhoun,
. 4, 2. . 2428. M.D. Esler // Med J Aust. 2003. Vol. 178, 6.
11. ..  P. 272276.
/ 24. Chamberlain A.M. Associations of preexisting depression
.. // Consilium medicum ( and anxiety with hospitalization in patients with
). 2011. 6. . 3035. cardiovascular disease / A.M. Chamberlain, K.S. Vickers,
12. ..  R.C. Colligan et al. // Mayo Clin Proc. 2011. Vol. 86,
/ .. , 11. P. 10561062.
.. , .. //  25. Cho E.Y. Determinants and trajectory of phobic anxiety
. 2008. . 4, 235. . 4555. in patients living with an implantable cardioverter
..
13. ..  defibrillator / E.Y. Cho, R. von Knel, B. MartenMittag
/ .. , et al. // Heart. 2012. Vol. 98, 10. P. 806812.
.. // . 2005. 9. 26. Common mental health disorders. Identification and
. 5053. pathways to care. National Collaborating Centre for

77

2 2013

Mental Health. London (UK): National Institute for H. Kayano, S. Koba, T. Matsui // Circ J. 2012.
Health and Clinical Excellence (NICE); 2011 May. 61 p. Vol. 76, 7. P. 16701677.
(Clinical guideline; no. 123). 42. Lane D. Anxiety, depression, and prognosis after
27. Coryell W. Mortality among outpatients with anxiety myocardial infarctionIs there a causal association? /
disorders / W. Coryell, R. Noyes, J.D. Hause // Am. J. D. Lane, D. Carroll, G.Y.N. Lip // J. Am. Coll. Cardiol.
Psychiatry. 1986. Vol. 143. P. 508510. 2003. Vol. 42, 10. P. 18081810.
28. Davidson J.R. Management of Generalized Anxiety 43. Loane C. Buspirone: what is it all about? / C. Loane,
Disorder in Primary Care: Identifying the Challenges M. Politis // Brain Res. 2012. Vol. 1461. P. 111
and Unmet Needs / J.R. Davidson, D.E. Feltner, Ashish 118.
Dugar // Prim Care Companion J. Clin. Psychiatry. 44. Lo Turco G., Grimaldi Di Terresena L. Spectral analysis
2010. Vol. 12, 2. of Heart Rate Variability in psychiatric patients:
29. Davies S. Association of panic disorder and panic attack autonomic nervous system evaluation in psychotic,
with hypertension / S. Davies, P. Ghakramani, anxiety and depressive disorders / G. Lo Turco,
P.R. Jaerson et al. // Am. J. Med. 1999. Vol. 107, 4. L. Grimaldi Di Terresena // Riv Psichiatr. 2012.
P. 310316. Vol. 47, 2. P. 139148.
30. Dinan T.G. Inflammatory markers in depression / 45. Martens E.J. Scared to death? Generalized anxiety
T.G. Dinan // Curr Opin Psychiatry. 2009. Vol. 22, disorder and cardiovascular events in patients with
1. P. 3236. stable coronary heart disease / E.J. Martens, P. de Jonge,
31. Dolnak D.R. Treating Patients for Comorbid Beeya Na et al. // Arch Gen Psychiatry. 2010.
Depression, Anxiety Disorders, and Somatic Illnesses / Vol. 67, 7. P. 750758.
D.R. Dolnak // J. Am. Osteopath. Assoc. 2006. 46. MaurerSpurei E. Serotonin reuptake inhibitors and
Vol. 106, 5. S2. P. 18. cardiovascular diseases: a platelet connection /
32. Dornelas E.A. Stress Proof the heart. Behavioral E. MaurerSpurej // Cell Mol Life Sci. 2005. Vol. 62,
interventions for cardiac patients / E.A. Dornelas // 2. P. 159170.
Springer Science+Business Media, LLC New York, 2012. 47. Patten S.B. Anxiety Disorders and Cardiovascular
408 p. Disease Determinants in a Population Sample /
33. Faber J. Buspirone: a possible cause of alopecia / J. Faber, S.B. Patten, Ming Fu Liu // The Internet Journal of
R.A. Sansone // Innov Clin Neurosci. 2013. Vol. 10, Mental Health. 2007. Vol. 4, 1.
1. P. 13. 48. Rakel R.E. Longterm buspirone therapy for chronic
34. FrasureSmith N. Depression and anxiety as predictors anxiety: a multicenter international study to determine
of 2year cardiac events in patients with stable coronary safety / R.E. Rakel, E. Robert // South Med J. 1990.

artery disease / N. FrasureSmith, F. Lesprance // Arch Vol. 83, 2. P. 194198.
Gen Psychiatry. 2008. Vol. 65, 1. P. 6271. 49. Roest A.M. Prognostic Association of Anxiety Post
35. Geiser F. Anxiety disorders / F. Geiser, A. Kleiman, Myocardial Infarction With Mortality and New Cardiac
C. Albus et al. // Internist (Berl). 2012. Vol. 53, Events: A MetaAnalysis / A.M. Roest, E.J. Martens,
11. P. 12891290; 12921295. J. Denolett et al. // Psychosomatic Medicine. 2010.
36. Haines A.P. Phobic anxiety and ischaemic heart disease / Vol. 72. P. 563569.
A.P. Haines, J.D. Imeson, T.W. Meade // Br. Med. J. 50. Rowney J. Anxiety Disorders / In: Carey WD, ed.
1987. Vol. 295. P. 297299. Cleveland Clinic Current Clinical Medicine. Philadel
37. Hocaoglu C. Cardiac Diseases and Anxiety Disorders / phia, PA: Saunders; 2009. P. 983987.
Anxiety and Related Disorders, book edited by gnes 51. Schmidt M.M. Psychological characteristics of patients
Szirmai, 2011, CC BYNCSA 3.0 Chapter 8. undergoing percutaneous coronary interventions /
38. Hocelaoglu C. Cardiac diseases and anxiety disorders. M.M. Schmidt, A.S. Quadros, A.P. Abelin et al. // Arq
Anxiety and related disorders / C. Hocelaoglu, Bras Cardiol. 2011. Vol. 97, 4. P. 331337.
C.H. Yeloglu, S. Polat // Agnes Szirmai. In Tech. 2011. 52. Shulman J., Shapiro P.A. Depression and Cardiovascular
. 292. Disease. What Is the Correlation? / J. Schulman,
39. Jiang W. Relationship of depression to increased risk of P.A. Sharpio // Psychiatric Times. 2008. Vol. 25,
mortality and rehospitalization in patients with 9. P. 133141.
congestive heart failure / W. Jiang, J. Alexander, 53. Spielberger C.D., Rickman R.L. Assessment of State and
E. Christopher // Arch Intern Med. 2001. Vol. 161. Trait Anxiety in Cardiovascular Disorders /
P. 18491856. C.D. Spielberger, R.L. Rickman // In D.G. Byrne and
40. Kawachi I. Symptoms of anxiety and risk of coronary R.H. Rosenman (Eds.), Anxiety and the Heart (p. 73
heart disease The Normative Aging Study / I. Kawachi, 92). New York: Hemisphere Publishing Corporation.
D. Sparrow, P.S. Vokonas et al. // Circulation. 1994. 54. Steffens D.C. Antidepressant Treatment Treatment and
Vol. 90. P. 22252229. Worsening White Matter on Serial Cranial Magnetic
41. Kayano H. Anxiety disorder is associated with nocturnal Resonance Imaging in the Elderly / D.C. Steffens,
and early morning hypertension with or without W.T. Longstreth // Stroke. 2008. Vol. 39. P. 857
morning surge: ambulatory blood pressure monitoring / 862.

78

2 2013

55. Strine T.W. Associations of selfreported anxiety 59. Yohannes A.M. Depression and anxiety in chronic heart
symptoms with healthrelated quality of life and health failure and chronic obstructive pulmonary disease:
behaviors / T.W. Strine, D.P. Chapman, R. Kobau et al. // prevalence, relevance, clinical implications and
Soc Psychiatry Psychiatr Epidemiol. 2005. Vol. 40, management principles / A.M. Yohannes, T.G. Willgoss,
6. P. 432438. R.C. Baldwin et al. // Int. J. Geriatr. Psychiatry. 2010.
56. Thornton E.W. Anxiety, Depression and Myocardial Vol. 25, 12. P. 12091221.
Infarction: A Survey of Their Impact on Consultation 60. Young Q.R. Brief screen to identify 5 of the most
Rates Before and After an Acute Primary Episode / common forms of psychosocial distress in cardiac
E.W. Thornton, P. Bundred, M. Tytherleight et al. // Br. patients: validation of the screening tool for
J. Cardiol. 2006. Vol. 13, 3. P. 220224. psychological distress / Q.R. Young, A. Ignaszewski,
57. Tseng Y.L. A selective serotonin reuptake inhibitor, D. Fotonoff // J. Cardiovasc. Nurs. 2007. Vol. 22,
citalopram, inhibits collageninduced platelet aggregation 6. P. 525534.
and activation / Y.L. Tseng, M.L. Chiang, T.F. Huang // 61. Zafar M.U. Anxiety is a better predictor of platelet
Thromb Res. 2010. Vol. 126, 6. . 517523. reactivity in coronary artery disease patients than
58. Vieweg W.V. Proarrhythmic risk with antipsychotic and depression / M.U. Zafar, M. PazYepes, D. Shimbo et al. //
antidepressant drugs: implications in the elderly / European Heart Journal. 2010. Vol. 31. P. 1573
W.V. Vieweg, M.A. Wood, A. Fernandez et al. // Drugs 1582.
Aging. 2009. Vol. 26, 12. P. 9971012.


.. , .. , .. , ..
.
, - , . -
, ( -
, , , -
), . ,
.
: .

Anxiety disorders and cardiovascular disease


N.T. Vatutin, M.. Khristichenko, E.V. Kartamysheva, E.V. Keting
SUMMARY. This is a review of recent published data about one of the most common mental disorder
accompanying cardiovascular diseases anxiety disorders. Its history and epidemiology are discussed.
The main mechanisms of the development of this disease (autonomic nervous system dysfunction, lipid
metabolism disorders, platelet function impairment, hyper production of anti-inflammatory cytokines,
etc.) are discussed. The peculiarities of clinic, methods of diagnostics and treatment are disclosed.
Key words: anxiety disorders.
:

. .
83003, , . , 16

79

Оценить